Infusion of docosahexaenoic acid protects against myocardial infarction

Author(s): Richard D,Oszust F, Guillaume C,Millart H, Laurent-Maquin D, et al.


Most of the cardioprotective effects of long-chain omega 3 fatty acids, namely docosahexaenoic (DHA; 22:6n-3) and eicosapentaenoic (EPA; 20:5n-3), are due to their hypotriglyceridemic and anti-inflammatory effects, which lower the risk for cardiovascular disease and myocardial infarction. Little is known on the direct preventive activities of DHA and EPA on heart function. In isolated hearts, we studied (1) whether infused DHA is able to protect the heart from ischemia/reperfusion damage and (2) the role played by Notch-mediated signal transduction pathways in myocardial infarction. Perfusion with DHA before and before/after induction of ischemia reperfusion significantly diminished cardiac damage and afforded antioxidant protection. Mechanistically, infusion of DHA before and before/after the induction of ischemia differentially modulated the expression of Notch2 and 3 target genes. In particular, DHA increased the expression of Hey1 when infused pre- and pre/post-ischemia; Jagged 1 and the Notch2 receptors increased with DHA pre-ischemia, but not pre/post; Notch2 and 3 receptors as well as Delta increased following DHA administration pre- and (especially) pre/post-ischemia. In conclusion, while the precise nature of the Notch-mediated protection from ischemia/reperfusion afforded by DHA is as yet to be fully elucidated, our data add to the growing body of literature that indicates how systemic administration of DHA provides cardiovascular protection.

Similar Articles

Heart disease and stroke statistics - 2014 update: a report from the American Heart Association

Author(s): Go AS, Dariush M, Véronique L, Emelia JB, Jarett DB, et al.

Nutritional assessment in heart failure patients

Author(s): Lee JH,Jarreau T, Prasad A, Lavie C, O'Keefe J, et al.

Aging and energetics' 'Top 40' future research opportunities 2010-2013

Author(s): Allison DB, Antoine LH, Ballinger SW, Bamman MM, Biga P, et al.

Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence

Author(s): Lorente-Cebrián S, Costa AG, Navas-Carretero S, Zabala M, Martínez JA, et al.

Omega-3 fatty acids: a growing ocean of choices

Author(s): Fares H,Lavie CJ, DiNicolantonio JJ, O'Keefe JH, Milani RV

Omega-3s and cardiovascular health

Author(s): DiNicolantonio JJ,Niazi AK, McCarty MF, O'Keefe JH, Meier P, et al.

The cardiovascular effects of flaxseed and its omega-3 fatty acid, alpha-linolenic acid

Author(s): Rodriguez-Leyva D,Dupasquier CM, McCullough R, Pierce GN

Comparative effects of DHA and EPA on cell function

Author(s): Gorjão R,Azevedo-Martins AK, Rodrigues HG, Abdulkader F, Arcisio-Miranda M, et al.

Pleiotropic effects of omega-3 fatty acids

Author(s): Papazafiropoulou AK,Kardara MS, Pappas SI

Omega-3 fatty acids and HDL

Author(s): Burillo E, Martín-Fuentes P, Mateo-Gallego R, Baila-Rueda L, Cenarro A, et al.

Omega-3 fatty acids and depression: scientific evidence and biological mechanisms

Author(s): Grosso G,Galvano F,Marventano S,Malaguarnera M,Bucolo C, et al.